Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC05 - Novel Drugs in Thoracic Cancers
- Type: Science Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:R. Herbst
- Coordinates: 12/05/2016, 11:00 - 12:30, Hall C2
-
+
SC05.02 - Novel Cytotoxic Drugs in Lung Cancer
11:20 - 11:40 | Author(s): J. Soria
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA06 - Prognostic & Predictive Biomarkers
- Type: Oral Session
- Track: Biology/Pathology
- Presentations: 8
- Moderators:F. Shepherd
- Coordinates: 12/05/2016, 14:20 - 15:50, Strauss 1
-
+
OA06.05 - Proteomic Analysis of ERCC1 Predicts Benefit of Platinum Therapy in NSCLC: A Reevaluation of Samples from the TASTE Trial
15:05 - 15:15 | Author(s): J. Soria
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ISS09 - Industry Supported Symposium: Targeted Therapy on the Horizon for SCLC - AbbVie
- Type: Industry Supported Symposium
- Track:
- Presentations: 5
- Moderators:M. Reck
- Coordinates: 12/06/2016, 07:30 - 08:30, Lehar 3-4
-
+
ISS09.02 - Advancing the Study in SCLC – What is the Underlying Biology?
07:40 - 07:55 | Author(s): J. Soria
- Abstract
No abstract available for this presentation
-
+
ISS09.04 - Panel Discussion: Looking Over the Horizon – Future Treatment of SCLC
08:15 - 08:25 | Author(s): M. Reck
- Abstract
No abstract available for this presentation
-
+
ISS09.05 - Question & Answer
08:25 - 08:30 | Author(s): M. Reck
- Abstract
No abstract available for this presentation
-
+
PL03 - Presidential Symposium
- Type: Plenary
- Track:
- Presentations: 10
- Moderators:D.P. Carbone
- Coordinates: 12/06/2016, 08:35 - 10:25, Hall D (Plenary Hall)
-
+
PL03.07 - First-line Ceritinib Versus Chemotherapy in Patients With ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4) (Abstract under Embargo until December 6, 7:00 CET)
09:45 - 09:55 | Author(s): G. De Castro Jr
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Treatment Monitoring in Advanced NSCLC
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Presentations: 12
- Moderators:R. Perez-Soler
- Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 3-4
-
+
MA08.01 - A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma
11:00 - 11:06 | Author(s): H. Wakelee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA11 - Novel Approaches in SCLC and Neuroendocrine Tumors
- Type: Mini Oral Session
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 12
- Moderators:P. Lara
- Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 3
-
+
MA11.02 - Mutational Burden in Pulmonary Neuroendocrine Tumors (puNETs)
14:26 - 14:32 | Author(s): I. Sullivan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-050 - Prognostic Value of HLA-A2 Status in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
14:30 - 14:30 | Author(s): L. Mezquita
- Abstract
Loading...
-
+
PL04a - Plenary Session: Immune Checkpoint Inhibitors in Advanced NSCLC
- Type: Plenary
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:J. Soria
- Coordinates: 12/07/2016, 08:45 - 09:40, Hall D (Plenary Hall)
-
+
PL04a.01 - Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024 (Abstract under Embargo until December 7, 7:00 CET)
08:45 - 08:55 | Author(s): J.R. Brahmer
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL04a.02 - OAK, a Randomized Ph III Study of Atezolizumab vs Docetaxel in Patients with Advanced NSCLC: Results from Subgroup Analyses (Abstract under Embargo until December 7, 7:00 CET)
08:55 - 09:05 | Author(s): S.M. Gadgeel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL04a.03 - Durvalumab in ≥3rd-Line Locally Advanced or Metastatic, EGFR/ALK Wild-Type NSCLC: Results from the Phase 2 ATLANTIC Study (Abstract under Embargo until December 7, 7:00 CET)
09:05 - 09:15 | Author(s): M.C. Garassino
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL04a.04 - Multicentric French Harmonization Study for PD-L1 IHC Testing in NSCLC (Abstract under Embargo until December 7, 7:00 CET)
09:15 - 09:25 | Author(s): J. Adam
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL04a.05 - Discussant for PL04a.01, PL04a.02, PL04a.03, PL04a.04
09:25 - 09:40 | Author(s): M. Boyer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA23 - EGFR Targeted Therapies in Advanced NSCLC
- Type: Oral Session
- Track: Advanced NSCLC
- Presentations: 8
- Moderators:O.T. Brustugun
- Coordinates: 12/07/2016, 14:20 - 15:50, Stolz 2
-
+
OA23.03 - Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial
14:40 - 14:50 | Author(s): G. Goss
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.02a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 37
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02a-025 - PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4)
14:30 - 14:30 | Author(s): D. Tan
- Abstract
Loading...